The Government has today responded to the Health Select Committee’s report into the state of community pharmacy, addressing each of the report’s recommendations to support the sector. In its response, the Government has reaffirmed its ambition to expand the role of pharmacies and to improve workforce planning, but it has not set out answers to
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes. MSN/2025/002 Tier 2 – medium impact Date of issue: 9th January 2025 APO-go® (apomorphine hydrochloride) PFS are being discontinued; supplies are anticipated to be exhausted from early April 2025. APO-go® POD
Read moreMHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) Drug alert number: EL (25)A/01 Date issued: 09 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) DMRC
Read moreDate issued: 8 January 2025 TriOn Pharma is recalling two food supplement products. Aactive D3 Drops and Aactive D3 Solution because they contain higher levels of vitamin D3 than written on the label. Aactive D3 2,000iu/ml Oral Drops Batch No Expiry Date Pack Size LS23317 November 2025 20ml Aactive D3 2,000iu/ml Oral Solution Batch No
Read moreFollowing on from much Parliamentary activity before Christmas, such as the debate on pharmacy funding in the South West and the Health secretary’s appearance before the Health Committee, MPs are continuing to highlight the serious challenges pharmacies face and to call for support for the sector. Debate on NHS backlogs On Monday, in a debate
Read moreWith New Year’s Day (1 January 2025) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 January 2025, to submit their December FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 8 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 January 2025. This takes the total
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/12/2024) announced the following list of price concessions for December 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £12.75 Aqueous cream 500 £5.17 Ascorbic acid 100mg tablets
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 January 2025. From 1 January 2025, Original Pack Dispensing (+/-10% OPD) rules have been introduced in The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2)
Read moreThe Drug Tariff Category M pricelist for January 2025 has been published on the NHS Business Services Authority (NHSBSA) website. Based on our analysis of the Category M price list for January 2025, Community Pharmacy England estimates there will be an overall reduction in reimbursement of approximately -£34m per quarter, resulting from the combination of: A
Read more
